1. Home
  2. ENVX vs FTH Comparison

ENVX vs FTH Comparison

Compare ENVX & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

N/A

Current Price

$2.74

Market Cap

612.3M

Sector

Miscellaneous

ML Signal

N/A

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$21.81

Market Cap

507.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENVX
FTH
Founded
2006
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
612.3M
507.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ENVX
FTH
Price
$2.74
$21.81
Analyst Decision
Buy
Strong Buy
Analyst Count
12
15
Target Price
$9.75
★ $55.31
AVG Volume (30 Days)
★ 10.0M
351.3K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.94
N/A
EPS
★ N/A
N/A
Revenue
★ $31,821,000.00
N/A
Revenue This Year
$23.31
N/A
Revenue Next Year
$93.03
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 37.91
N/A
52 Week Low
$2.20
$16.57
52 Week High
$9.89
$42.14

Technical Indicators

Market Signals
Indicator
ENVX
FTH
Relative Strength Index (RSI) 47.44 46.98
Support Level $2.34 $16.57
Resistance Level $3.01 $21.97
Average True Range (ATR) 0.34 2.02
MACD -0.01 0.65
Stochastic Oscillator 38.77 87.41

Price Performance

Historical Comparison
ENVX
FTH

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: